China stocks rally with 4,300 gainers; pharma surges on AI drug policy
Chinese stock markets rose on September 21, with the ChiNext index up 0.93% and over 4,300 stocks advancing. Half-day turnover reached 1.33 trillion yuan. The pharmaceutical sector led gains after ten ministries issued the 15th Five-Year Plan for Pharmaceutical Industry Development on September 18, promoting AI and quantum computing in drug R&D. PCB and elderly care stocks also rose, while robotics stocks gained on Tesla Optimus production line progress.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary awaiting refresh
Summary awaiting refresh
Cross-source coverage
Reporting timeline
China stocks rebound led by healthcare; PCB, real estate, robotics also gain
On September 21, China's three major stock indices rebounded, with the Shanghai Composite Index rising 0.97%, the Shenzhen Component Index up 0.65%, and the ChiNext Index gaining 0.8%. Over 4,200 stocks rose, with total turnover reaching approximately 2.03 trillion yuan. The healthcare sector led gains, driven by innovative drugs, medical services, and CRO stocks, following the September 18 release of the 'Fifteenth Five-Year Plan' for the pharmaceutical industry by ten government departments including the Ministry of Industry and Information Technology. The plan calls for accelerating AI, quantum computing, and computational medicine in drug R&D. CITIC Securities noted that China's innovative drug sector is entering a global value realization phase. PCB concept stocks were active amid reports of price renegotiations by manufacturers, with brokerages forecasting a profit improvement inflection point in Q3 2026. Real estate stocks rose following a State Council Information Office press conference where Vice Minister Chen Shaowang described the sector as being in a critical transformation period. Robotics concept stocks strengthened on news that Tesla's Optimus production line in Texas may be nearing structural completion, targeting 10 million units annual capacity by 2027. Precious metals, semiconductor, and CPO concept stocks declined.
Read sourceChina Stocks Rise as Pharma Surges on AI Drug Policy, Tesla Robotaxi Supply Chain News
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, led by a broad rally in the pharmaceutical sector after China's Ministry of Industry and Information Technology and nine other departments jointly issued the '15th Five-Year Plan for Pharmaceutical Industry Development' on September 18. The plan calls for accelerating the use of artificial intelligence, quantum computing, and computational medicine in drug R&D. CITIC Securities commented that China's innovative drug companies are entering a global value realization phase. PCB stocks also rose on reports of price transmission improvements, with brokerages forecasting a profit inflection point in Q3 2026. The elderly care sector gained after a State Council meeting on September 18 addressed the aging population, with projections that China's silver economy will reach 30 trillion yuan by 2030. Robot concept stocks rose on news that Tesla's Optimus production line in Texas may be nearing completion, targeting 10 million units annual capacity by 2027. Separately, a supply chain source said Tesla's robot team conducted factory inspections at several Yangtze River Delta suppliers including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, with orders already secured.
Read sourceChina Stocks Rise as Pharma Surges on AI Drug Policy, Tesla Robot News
Chinese stock markets rose on September 21, with the ChiNext index gaining nearly 1% and over 4,300 stocks advancing. The pharmaceutical sector led gains after China's工信部 (Ministry of Industry and Information Technology) and nine other departments jointly issued the '15th Five-Year Plan for Pharmaceutical Industry Development' on September 18, which calls for accelerating the use of artificial intelligence, quantum computing, and computational medicine in drug R&D. CITIC Securities commented that China's innovative drug companies are entering a global value realization phase. PCB stocks also rallied on expectations of a price transmission mechanism recovery by Q3 2026. The elderly care sector rose following a State Council meeting on September 18 addressing population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks gained after a drone video showed Tesla's Optimus production line in Texas nearing completion, with a planned 2027 launch and annual capacity target of 10 million units. Tesla's robot team also conducted factory inspections in China's Yangtze River Delta region, with orders already placed at suppliers including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics.
Read sourceShow 12 older updatesHide older updates
China Stocks Rise as Pharma Surges on AI Drug Policy, Tesla Robotaxi Supply Chain News
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, with total half-day turnover reaching 1.33 trillion yuan. The pharmaceutical sector led gains, driven by a September 18 policy from ten Chinese ministries including the Ministry of Industry and Information Technology, which released the '15th Five-Year Plan for Pharmaceutical Industry Development' promoting AI, quantum computing, and computational medicine in drug R&D. CITIC Securities noted that Chinese innovative drug companies are entering a global value realization phase. PCB stocks also rose as multiple brokerages forecast a profit inflection point in Q3 2026 due to raw material price pass-through. The elderly care sector gained after a September 18 State Council meeting on aging population policy, with the silver economy projected to reach 30 trillion yuan by 2030. Robot concept stocks rose on reports that Tesla's Optimus team is conducting factory audits at supply chain companies in the Yangtze River Delta, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, with orders already placed ahead of planned 2027 production.
Read sourceChina Stocks Rise as Pharma Surges on AI Drug Policy; Tesla Robotaxi Supply Chain Advances
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced amid strong trading volume of 1.33 trillion yuan. The pharmaceutical sector led gains following the September 18 release of the '15th Five-Year Plan for Pharmaceutical Industry Development' by ten Chinese ministries, which promotes AI, quantum computing, and supercomputing in drug R&D. CITIC Securities noted that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rose as analysts expect a Q3 2026 profit inflection point due to raw material price pass-through. The elderly care sector gained after a State Council meeting on September 18 addressed population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks rose on reports that Tesla's Optimus production line in Texas may be nearing completion, targeting 10 million units annual capacity by 2027. Separately, Hainan province is advancing a space tourism platform, and Tesla's humanoid robot team is conducting supply chain audits in the Yangtze River Delta region, with orders already placed at several suppliers.
Read sourceChina Stocks Rise on Pharma, Robot, PCB Gains; Over 4,300 Shares Advance
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, with total half-day turnover reaching 1.33 trillion yuan. The pharmaceutical sector led gains following the September 18 release of the '15th Five-Year Plan for Pharmaceutical Industry Development' by ten ministries, which promotes AI and quantum computing in drug R&D. CITIC Securities noted that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rose as multiple brokerages forecast a profit inflection point in Q3 2026 due to raw material price pass-through. The elderly care sector gained after a State Council meeting on September 18 addressed population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks rose on reports that Tesla's Optimus production line in Texas may be nearing completion, targeting 10 million units annual capacity by 2027. Separately, Hainan province is advancing a space tourism platform, and Tesla's humanoid robot team is conducting factory audits in the Yangtze River Delta region, with orders already placed at several suppliers.
Read sourceChina Stocks Rise on Pharma, Robot, PCB Gains; Over 4,300 Shares Advance
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, with total half-day turnover reaching 1.33 trillion yuan. The pharmaceutical sector led gains, driven by the Ministry of Industry and Information Technology's '15th Five-Year Plan' for the pharmaceutical industry, which promotes AI and quantum computing in drug R&D. CITIC Securities noted that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rose on expectations of a Q3 2026 profit inflection point as raw material prices increase. The elderly care sector gained after a State Council meeting on aging population policies. Robotics stocks rose on reports that Tesla's Optimus production line in Texas is nearing completion, with a 2027 target of 10 million units annually. Tesla's robot team also conducted factory inspections in China's Yangtze River Delta region, with orders already placed with suppliers including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics.
Read sourceChina Stocks Rise on Pharma, Robot, and Pension Sector Gains; Over 4,300 Shares Up
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, driven by a broad rally in the pharmaceutical sector, including AI drug development and CRO stocks, following the release of the '15th Five-Year Plan' for the pharmaceutical industry by ten government departments. The plan promotes AI, quantum computing, and other technologies in drug R&D. CITIC Securities forecasts that China's innovative drug companies are entering a global value realization phase. PCB stocks also gained on expectations of a profit inflection point in Q3 2026 due to rising raw material prices. The pension sector rose after a State Council meeting on aging population policies, with the silver economy projected to reach 30 trillion yuan by 2030. Robot stocks advanced on news that Tesla's Optimus production line in Texas may be near completion, targeting 10 million units annual capacity by 2027. Tesla's robot team is also conducting factory audits in the Yangtze River Delta region, with orders already placed with suppliers like Tuopu Group and Sanhua Intelligent Controls.
Read sourceChina Stocks Rise on Pharma, Robot, PCB Gains; Over 4,300 Shares Advance
Chinese stocks rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, driven by a broad rally in the pharmaceutical sector, including AI drug development and CRO stocks, after China's工信部 (Ministry of Industry and Information Technology) and nine other departments jointly issued the '15th Five-Year Plan for Pharmaceutical Industry Development' on September 18, calling for AI, quantum computing, and computational medicine to empower drug R&D. CITIC Securities forecast that China's innovative drug companies are entering a global value realization phase. PCB stocks also gained on expectations of a pricing recovery by Q3 2026. The elderly care sector rose after a State Council meeting on September 18 addressed the aging population, with the silver economy projected to reach 30 trillion yuan by 2030. Robot stocks rallied on reports that Tesla's Optimus production line in Texas may be near completion, targeting 10 million units annual capacity by 2027. Tesla's robot team also conducted factory inspections in the Yangtze River Delta region, with orders already placed with suppliers including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics.
Read sourceChina Stocks Rise on Pharma, Robot, PCB Gains; Over 4,300 Shares Advance
Chinese equities rose on September 21, with the ChiNext index gaining 0.93% and the Shanghai Composite up 0.55%, as over 4,300 stocks advanced. The pharmaceutical sector led gains after China's Ministry of Industry and Information Technology and nine other departments jointly issued the '15th Five-Year Plan for Pharmaceutical Industry Development' on September 18, calling for AI, quantum computing, and computational medicine to empower drug R&D. CITIC Securities forecast that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rallied on expectations of a Q3 2026 profit inflection point as raw material prices rise. The elderly care sector rose following a State Council meeting on September 18 addressing population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks gained after a drone video showed Tesla's Optimus production line in Texas nearing completion, targeting 10 million units annual capacity by 2027. Tesla's robot team also conducted factory audits at supply chain companies in the Yangtze River Delta, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, with orders already placed. Hainan province is advancing a space tourism platform with signed cooperation agreements.
Read sourceChina Stocks Rise on Pharma, Robot, PCB Gains; Over 4,300 Shares Advance
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, the Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced, with total half-day turnover reaching 1.33 trillion yuan. The pharmaceutical sector led gains following the September 18 release of the '15th Five-Year Plan for Pharmaceutical Industry Development' by ten government departments, which promotes AI and quantum computing in drug R&D. CITIC Securities noted that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rose as multiple brokerages forecast that price transmission mechanisms are clearing, with Q3 2026 seen as a profit improvement inflection point. The elderly care sector gained after a State Council meeting on September 18 addressed population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks rose on reports that Tesla's Optimus production line in Texas may be near completion, targeting 10 million units annual capacity by 2027. A separate industry source reported that Tesla's robot team has begun factory inspections at supply chain companies in the Yangtze River Delta, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, with orders already placed.
Read sourceChina Stocks Rise as Pharma Surges on AI Drug Policy, Tesla Robotaxi Supply Chain News
Chinese stock markets rose on September 21, with the ChiNext index gaining nearly 1% and over 4,300 stocks advancing. The pharmaceutical sector led gains after China's工信部 (Ministry of Industry and Information Technology) and nine other departments jointly issued the '15th Five-Year Plan for Pharmaceutical Industry Development' on September 18, which calls for accelerating AI, quantum computing, and computational medicine in drug R&D. CITIC Securities commented that China's innovative drug companies are entering a global value realization phase. PCB stocks also rose as multiple brokerages noted that price transmission mechanisms are clearing, with Q3 2026 seen as a potential profit inflection point. The elderly care sector gained on a State Council meeting discussing the aging population, with silver economy projected to reach 30 trillion yuan by 2030. Robot concept stocks rose after a drone video showed Tesla's Optimus production line in Texas nearing completion, targeting 10 million units annual capacity by 2027. Separately, Hainan province is advancing a space tourism platform, and Tesla's humanoid robot team has begun factory inspections at supply chain companies in the Yangtze River Delta, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, signaling progress toward mass production.
Read sourceChina stocks rise with 4,300 gainers; pharma, PCB, robotics sectors lead
Chinese stock markets rose on September 21, with the Shanghai Composite up 0.55%, Shenzhen Component up 0.57%, and the ChiNext Index up 0.93%. Over 4,300 stocks advanced on half-day turnover of 1.33 trillion yuan. The pharmaceutical sector led gains, driven by AI drug development and CRO concepts, following the September 18 release of the '15th Five-Year Plan for Pharmaceutical Industry Development' by ten ministries including MIIT. The plan promotes AI, quantum computing, and computational medicine in drug R&D. CITIC Securities forecasts that Chinese innovative drug companies are entering a global value realization phase. PCB stocks rose on expectations of a Q3 2026 profit inflection point as raw material prices increase. The elderly care sector gained after a State Council meeting on September 18 addressed population aging, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks rose on reports that Tesla's Optimus production line in Texas may be nearing completion, targeting 10 million units annual capacity by 2027. Tesla's robot team is also conducting factory audits at supply chain companies in the Yangtze River Delta region, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, with orders already placed.
Read sourceChina stocks rise on pharma, PCB, and robot sector gains; over 4,300 stocks up
Chinese stock markets rose on September 21, with the ChiNext index up 0.93% and over 4,300 stocks gaining. The pharmaceutical sector led, driven by a government '15th Five-Year Plan' for the industry, which promotes AI and quantum computing in drug R&D. PCB stocks also rose on expectations of price hikes and improved profitability by Q3 2026. The elderly care sector gained after a State Council meeting on aging population policies, with the silver economy projected to reach 30 trillion yuan by 2030. Robotics stocks advanced on news that Tesla's Optimus production line in Texas may be near completion, with a 2027 target of 10 million units annual capacity. Separately, Hainan is advancing a space tourism platform, and Tesla's robot team is conducting factory audits in the Yangtze River Delta, with orders already placed with suppliers like Tuopu Group and Sanhua Intelligent Controls.
China stocks rise with 4,300+ gainers; pharma sector surges on 15th Five-Year Plan
Chinese stock markets opened higher on September 21, with the ChiNext index rising nearly 1% and over 4,300 stocks in the green. The Shanghai and Shenzhen indices traded in positive territory, with total half-day turnover reaching 1.33 trillion yuan, up 89 billion from the previous session. The pharmaceutical sector led gains, driven by a September 18 joint announcement from ten government ministries including the Ministry of Industry and Information Technology on the '15th Five-Year Plan for Pharmaceutical Industry Development', which calls for accelerating AI integration. CITIC Securities commented that innovative drug companies may enter a phase of global value realization. PCB concept stocks also rallied, with Guanghe Technology hitting the daily limit. The elderly care sector rose following a September 18 State Council meeting on addressing population aging, with projections that China's 60+ population will exceed 400 million by 2030. Robotics stocks strengthened amid reports that Tesla's robot team conducted supplier audits in Ningbo last week, signaling progress toward humanoid robot mass production. Separately, Hainan is advancing the formation of a space tourism platform with relevant entities having signed cooperation agreements.
Read source